Sirt1 Activation by Post-ischemic Treatment With Lumbrokinase Protects Against Myocardial Ischemia-Reperfusion Injury

• Main Authors: Yi-Hsin Wang (Author), Shun-An Li (Author), Chao-Hsin Huang (Author), Hsing-Hui Su (Author), Yi-Hung Chen (Author), Jinghua T. Chang (Author), Shiang-Suo Huang (Author)
• Format: Book
• Published: Frontiers Media S.A., 2018-06-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Lumbrokinase is used as an oral supplement to support and maintain healthy cardiovascular function, and to treat cardiovascular diseases in clinical for more than 10 years. Up until now, the mechanism of the cardioprotective effects of post-ischemic treatment with lumbrokinase has remained unclear....